Blood counts and nerve pain relief after a nerve block
Part of Brain & nervous system, Pain clinical trials.
This study looks at how blood cell counts change when you receive a nerve-blocking injection for neuropathic pain (nerve damage pain). Researchers want to understand if these blood changes can predict how well the injection will help your pain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with neuropathic pain (pain from nerve damage) confirmed by clinical tests
- You are receiving a sympathetic nerve block injection as part of your regular pain treatment
- You do not have active infections, cancer, or blood-related diseases
- You are not pregnant, breastfeeding, or on immunosuppressive medications or high-dose steroids
- You can provide written consent and have blood work done before and after your treatment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether a numbing “nerve block” can reduce long-lasting nerve pain caused by diabetic neuropathy. You may keep your usual pain medicines, and the study will mainly check whether you fit the safety and diagnosis criteria.
This study analyzes blood samples from people with diabetes to understand what causes nerve pain and damage in the legs and feet. Researchers will compare blood from three groups: people with diabetic nerve pain, people with diabetes but no nerve problems, and healthy volunteers without diabetes.
This trial tests a numbing medicine injected near a major leg nerve (femoral nerve) to see if it can reduce pain and improve function for people with diabetic peripheral neuropathy (nerve damage from diabetes).
This study aims to find a blood test that can predict which patients will develop nerve pain or numbness (peripheral neuropathy) from certain chemotherapy drugs. You may be eligible if you are about to start treatment with paclitaxel, docetaxel, or oxaliplatin for at least 9 weeks.
This study looks at how well a single nerve-numbing injection (injected near nerves in your shoulder) works to control pain during outpatient arthroscopic shoulder surgery. Researchers want to understand your pain relief experience before, during, and after the procedure.
This study looks at how the central nervous system reacts in people with type 2 diabetes who have or don't have pain from nerve damage. It aims to better understand nerve sensitivity to help improve treatment.
Hear when a new Neuropathic Pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.